The Weekly: FDA to regulate e-cigarettes using synthetic nicotine, cancer genetics to help with treatment and more

Published on April 22, 2022

Feature Story

FDA now able to regulate e-cigarettes that use synthetic nicotine

FRIDAY, April 15 (The Hill) — The Food and Drug Administration (FDA) now has oversight to regulate e-cigarette products from vaping companies operating under a loophole that was closed by a new law.

The law, which took effect Thursday, gives the FDA authority to regulate e-cigarettes and other products that use synthetic nicotine, a move that targets vaping companies that use manufactured nicotine to circumvent FDA regulation and sell the products to teenagers.

In other news. . .

Study mines cancer genetics to help with targeted treatment
April 21, The Washington Post




Hospitals’ massive cancer drug markups
April 19, Axios




This 35-year-old’s canker sore wouldn’t go away. It was stage 4 tongue cancer.
April 20, TODAY




Doctors suggest new names for low-grade prostate cancer
April 18, The Washington Post



Foundation News

Trusting your gut

If someone had told me a hurricane and a global pandemic would get in the way of me getting a colonoscopy, I wouldn’t have believed them. From learning I was lactose intolerant as a middle schooler to cutting gluten and other foods out of my diet throughout my 30s, I had been chasing gastrointestinal issues for years. My doctor recommended I get a colonoscopy, but I chalked up my symptoms to stomach troubles. I never thought it could be cancer.

Read more.

Sign up to get the latest about cancer prevention and early detection directly in your inbox.